Medication names
Pro Research Analysisby 
Searched over 200M research papers for "medication names"
Consensus Meter
Understanding Medication Names and Reducing Errors
Introduction to Medication Naming
The process of naming medications is intricate and involves multiple stages to ensure clarity and avoid confusion. Each drug receives three distinct names: the chemical name, the generic name, and the brand name. The chemical name specifies the molecular structure and is primarily used by researchers. The generic name is commonly used by healthcare professionals and must be approved by regulatory bodies like the U.S. Adopted Name (USAN) Council and the World Health Organization (WHO). The brand name, created by the manufacturer, is used for marketing purposes and must be approved by the FDA .
Common Issues with Drug Names
Look-Alike and Sound-Alike Drug Names
Medication errors often occur due to the similarity in drug names, which can look or sound alike. Examples include Celebrex® (celecoxib), Cerebyx® (fosphenytoin), and Celexa® (citalopram). Such confusion can lead to harmful medication errors, exacerbated by factors like poor handwriting and clinical similarity .
Naming Confusion in Different Contexts
Errors can also arise when different drugs have similar names, when formulations with the same brand name contain different drugs, or when the same drug is marketed under different names. Abbreviations of drug names further complicate the issue .
Strategies to Mitigate Medication Errors
Regulatory and Manufacturer Actions
Regulatory authorities and pharmaceutical manufacturers play crucial roles in mitigating these errors. They must maintain vigilance when naming new drugs and be prepared to change names if errors occur. Preapproval tests, such as computerized searches for existing similar names and expert judgments, can help identify potential confusion before a drug is marketed .
Healthcare Professional Practices
Healthcare professionals can reduce errors by using both the generic and brand names when prescribing medications. This practice helps distinguish between drugs with similar names. Additionally, prescribers should check unfamiliar names and consider the patient's current medications to avoid interactions .
Patient Involvement
Patients should be educated about their medications, including the risks associated with similar-sounding names. They should be encouraged to familiarize themselves with their medicines and communicate effectively with healthcare providers .
Design and Labeling Improvements
Tall Man Lettering
One effective strategy to reduce errors is the use of "Tall Man" lettering, where sections of drug names are printed in capital letters to emphasize differences between similar products. This method has been shown to reduce errors in identifying drugs.
Sound Symbolism in Drug Names
Research suggests that the sounds in drug names can influence perceptions. For instance, cancer medication names often contain voiceless consonants associated with lightness and fastness, which may affect how patients and providers perceive these drugs.
Conclusion
The naming of medications is a complex process involving multiple stakeholders and stringent guidelines to minimize confusion. Despite these efforts, errors due to similar drug names remain a significant concern. By implementing strategies such as Tall Man lettering, improving regulatory practices, and enhancing communication among healthcare providers and patients, the risk of medication errors can be significantly reduced.
Sources and full results
Most relevant research papers on this topic